RS
Ravi Shekhar Yellamanchili
About Ravi Shekhar Yellamanchili
Data last updated:
Ravi Shekhar Yellamanchili is a Director at Kims Super Speciality Hospital Private Limited (since 2012), Designated Partner at Fable Pharma Llp (since 2024) and Designated Partner at Vitazen Health Care Llp (since 2023), and holds 1 more current directorship. The companies operate in Healthcare and Business Services. The largest current company by reported revenue is Kims Super Speciality Hospital Private Limited at ₹21.79 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kims Super Speciality Hospital Private Limited U85110CT2004PTC016329 | Director | 31 Mar 2012 | 2004 | ₹21.79 Cr (FY 2025) | Active |
| Fable Pharma Llp ACF-2110 | Designated Partner | 31 Jan 2024 | 2024 | Active | |
| Vitazen Health Care Llp ACC-2320 | Designated Partner | 27 Jul 2023 | 2023 | Active | |
| Twin City Healthcare Private Limited U85110TG2010PTC067614 | Director | 18 May 2019 | 2010 | Active |
Board colleagues of Ravi Shekhar Yellamanchili
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kamla Yalmanchili | 00523000 | Kims Super Speciality Hospital Private Limited , Twin City Healthcare Private Limited | Director |
| Rajshekhar Yallamanchli | 09424837 | Kims Super Speciality Hospital Private Limited | Director |
| Irshad Ahmed Khan | 05204244 | Fable Pharma Llp | Designated Partner |
| Jay Singh Baghel | 10256813 | Vitazen Health Care Llp | Designated Partner |
| Sudha Ram | 10484974 | Vitazen Health Care Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Shekhar Yellamanchili
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Shekhar Yellamanchili
Ravi Shekhar Yellamanchili currently holds 4 directorships: Kims Super Speciality Hospital Private Limited (Director, since 31 Mar 2012, revenue ₹21.79 Cr (FY 2025)); Fable Pharma Llp (Designated Partner, since 31 Jan 2024); Vitazen Health Care Llp (Designated Partner, since 27 Jul 2023); Twin City Healthcare Private Limited (Director, since 18 May 2019).
Ravi Shekhar Yellamanchili was first appointed on 31 Mar 2012 as Director at Kims Super Speciality Hospital Private Limited. The most recent appointment on record is 31 Jan 2024 at Fable Pharma Llp.
The current boards of Ravi Shekhar Yellamanchili's companies include Kamla Yalmanchili (Kims Super Speciality Hospital Private Limited), Rajshekhar Yallamanchli (Kims Super Speciality Hospital Private Limited), Irshad Ahmed Khan (Fable Pharma Llp), Jay Singh Baghel (Vitazen Health Care Llp), Sudha Ram (Vitazen Health Care Llp).